Valerio De Stefano
Valerio De Stefano
Full Professor of Hematology, Catholic University, Italy
Adresse e-mail validée de
Citée par
Citée par
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
A Palumbo, S Bringhen, T Caravita, E Merla, V Capparella, V Callea, ...
The Lancet 367 (9513), 825-831, 2006
Inherited thrombophilia: pathogenesis, clinical syndromes, and management [see comments]
V De Stefano, G Finazzi, PM Mannucci
Cardiovascular events and intensity of treatment in polycythemia vera
R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ...
N Engl J Med 368, 22-33, 2013
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
V De Stefano, I Martinelli, PM Mannucci, K Paciaroni, P Chiusolo, ...
New England Journal of Medicine 341 (11), 801-806, 1999
Prevention of venous thromboembolism: International Consensus Statement Guidelines compiled in accordance with the scientific evidence
AN Nicolaides
International Angiology 20 (1), 1, 2001
Clinical profile of homozygous JAK2 617V> F mutation in patients with polycythemia vera or essential thrombocythemia
AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ...
Blood 110 (3), 840-846, 2007
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families
I Martinelli, PM Mannucci, V De Stefano, E Taioli, V Rossi, F Crosti, ...
Blood, The Journal of the American Society of Hematology 92 (7), 2353-2358, 1998
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
G Finazzi, V Brancaccio, M Moia, N Ciavarella, MG Mazzucconi, ...
The American journal of medicine 100 (5), 530-536, 1996
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism
J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ...
Thromb Haemost 86 (3), 809-816, 2001
Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
T Barbui, G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, ...
Blood 120 (26), 5128-5133, 2012
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera
R Landolfi, L Di Gennaro, T Barbui, V De Stefano, G Finazzi, RM Marfisi, ...
Blood 109 (6), 2446-2452, 2007
Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients
V De Stefano, P Chiusolo, K Paciaroni, I Casorelli, E Rossi, M Molinari, ...
Blood, The Journal of the American Society of Hematology 91 (10), 3562-3565, 1998
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with …
M Cavo, L Pantani, MT Petrucci, F Patriarca, E Zamagni, D Donnarumma, ...
Blood 120 (1), 9-19, 2012
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Micò, ...
haematologica 93 (3), 372-380, 2008
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
F Zaja, M Baccarani, P Mazza, M Bocchia, L Gugliotta, A Zaccaria, ...
Blood 115 (14), 2755-2762, 2010
Screening for inherited thrombophilia: indications and therapeutic implications
V De Stefano, E Rossi, K Paciaroni, G Leone
haematologica 87 (10), 1095-1108, 2002
Epidemiology of factor V Leiden: clinical implications
V de Stefano, P Chiusolo, K Paciaroni, G Leone
Seminars in thrombosis and hemostasis 24 (04), 367-379, 1998
Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium
I Martinelli, V De Stefano, E Taioli, K Paciaroni, E Rossi, MM Pier
Thrombosis and haemostasis 87 (05), 791-795, 2002
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
V De Stefano, A Fiorini, E Rossi, T Za, G Farina, P Chiusolo, S Sica, ...
Journal of Thrombosis and Haemostasis 5 (4), 708-714, 2007
Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of …
V De Stefano, G Leone, S Mastrangelo, A Tripodi, F Rodeghiero, ...
Thrombosis and haemostasis 72 (09), 352-358, 1994
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20